These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

283 related items for PubMed ID: 26692273

  • 1. First Pharmacological Therapy for Hypoactive Sexual Desire Disorder in Premenopausal Women: Flibanserin.
    Robinson K, Cutler JB, Carris NW.
    Ann Pharmacother; 2016 Feb; 50(2):125-32. PubMed ID: 26692273
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and Safety of Flibanserin for the Treatment of Hypoactive Sexual Desire Disorder in Women: A Systematic Review and Meta-analysis.
    Jaspers L, Feys F, Bramer WM, Franco OH, Leusink P, Laan ET.
    JAMA Intern Med; 2016 Apr; 176(4):453-62. PubMed ID: 26927498
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Flibanserin for Hypoactive Sexual Desire Disorder: An Open-Label Safety Study.
    Simon JA, Derogatis L, Portman D, Brown L, Yuan J, Kissling R.
    J Sex Med; 2018 Mar; 15(3):387-395. PubMed ID: 29502984
    [Abstract] [Full Text] [Related]

  • 6. Flibanserin for the treatment of hypoactive sexual desire disorder in premenopausal women.
    Dhanuka I, Simon JA.
    Expert Opin Pharmacother; 2015 Mar; 16(16):2523-9. PubMed ID: 26395164
    [Abstract] [Full Text] [Related]

  • 7. Flibanserin for Premenopausal Hypoactive Sexual Desire Disorder: Pooled Analysis of Clinical Trials.
    Simon JA, Thorp J, Millheiser L.
    J Womens Health (Larchmt); 2019 Jun; 28(6):769-777. PubMed ID: 30707049
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Treatment of hypoactive sexual desire disorder in premenopausal women: efficacy of flibanserin in the DAISY study.
    Thorp J, Simon J, Dattani D, Taylor L, Kimura T, Garcia M, Lesko L, Pyke R, DAISY trial investigators.
    J Sex Med; 2012 Mar; 9(3):793-804. PubMed ID: 22239862
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of safety for flibanserin.
    Clayton AH, Brown L, Kim NN.
    Expert Opin Drug Saf; 2020 Jan; 19(1):1-8. PubMed ID: 31855607
    [Abstract] [Full Text] [Related]

  • 13. Treatment of hypoactive sexual desire disorder in premenopausal women: efficacy of flibanserin in the VIOLET Study.
    Derogatis LR, Komer L, Katz M, Moreau M, Kimura T, Garcia M, Wunderlich G, Pyke R, VIOLET Trial Investigators.
    J Sex Med; 2012 Apr; 9(4):1074-85. PubMed ID: 22248038
    [Abstract] [Full Text] [Related]

  • 14. Flibanserin for female sexual dysfunction.
    Reviriego C.
    Drugs Today (Barc); 2014 Aug; 50(8):549-56. PubMed ID: 25187905
    [Abstract] [Full Text] [Related]

  • 15. Efficacy and safety of flibanserin in postmenopausal women with hypoactive sexual desire disorder: results of the SNOWDROP trial.
    Simon JA, Kingsberg SA, Shumel B, Hanes V, Garcia M, Sand M.
    Menopause; 2014 Jun; 21(6):633-40. PubMed ID: 24281236
    [Abstract] [Full Text] [Related]

  • 16. Flibanserin and its discontents.
    Aftab A, Chen C, McBride J.
    Arch Womens Ment Health; 2017 Apr; 20(2):243-247. PubMed ID: 27858170
    [Abstract] [Full Text] [Related]

  • 17. Open-label extension study of flibanserin in women with hypoactive sexual desire disorder.
    Jayne C, Simon JA, Taylor LV, Kimura T, Lesko LM, SUNFLOWER study investigators.
    J Sex Med; 2012 Dec; 9(12):3180-8. PubMed ID: 23057791
    [Abstract] [Full Text] [Related]

  • 18. Systematic Review and Meta-analysis of Flibanserin's Effects and Adverse Events in Women with Hypoactive Sexual Desire Disorder.
    Saadat SH, Kabir A, Rahmani K, Panahi Y, Hosseinialhashemi M, Sahebkar A.
    Curr Drug Metab; 2017 Dec; 18(1):78-85. PubMed ID: 27784209
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Continued efficacy and safety of flibanserin in premenopausal women with Hypoactive Sexual Desire Disorder (HSDD): results from a randomized withdrawal trial.
    Goldfischer ER, Breaux J, Katz M, Kaufman J, Smith WB, Kimura T, Sand M, Pyke R.
    J Sex Med; 2011 Nov; 8(11):3160-72. PubMed ID: 21933348
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.